Thryv Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Press Releases
Written By Thryv Therapeutics

  • Thryv to present on Tuesday, April 16th, 2024, from 3:00 p.m. to 3:30 p.m. ET.

Montreal, Quebec – April 9, 2024 – Thryv Therapeutics is pleased to announce its selection as a featured presenter at the 2024 Bloom Burton & Co. Healthcare Investor Conference. The virtual presentation will take place on Tuesday, April 16th, 2024, from 3:00 p.m. to 3:30 p.m. ET.

The Thryv team will also be available for one-on-one meetings throughout the day on Tuesday, April 16th and Wednesday, April 17th. To schedule one-on-one meetings with the team, please contact admin@thryvtrx.com.

About Thryv Therapeutics Inc.

Thryv Therapeutics Inc. is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat indications including Congenital Long QT Syndromes (LQTS), atrial fibrillation and heart failure, with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase (SGK1). For more information, please visit www.thryvtrx.com. 

Media Inquiries

daphne@thryvtrx.com | 514 973 0915

Thryv Therapeutics
Previous

Thryv Therapeutics to Participate at the Piper Sandler Spring Biopharma Symposium
Next

Thryv Therapeutics to Present Results of Wave I Part 1 Clinical Study at American College of Cardiology Conference in Atlanta, Georgia on April 7th, 2024